Nasal Cavity Clinical Trials

• Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084435 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Docetaxel Based Chemotherapy Plus Or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
  ClinicalTrials.gov Identifier: NCT00117572 - Recruiting
  Cancer of the Pharynx; Cancer of the Larynx; Cancer of the Nasal Cavity; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003576 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003200 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095641 - Not yet recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Study of Nasal Irrigation Versus Nasal Spray for Chronic Nasal and Sinus Symptoms
  ClinicalTrials.gov Identifier: NCT00318006 - Active, not recruiting
  Chronic Rhinosinusitis
  
• BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00057850 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00004226 - Active, not recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
  ClinicalTrials.gov Identifier: NCT00007982 - Recruiting
  adult brain tumor; paranasal sinus and nasal cavity cancer; primary central nervous system lymphoma
  
• Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity
  ClinicalTrials.gov Identifier: NCT00513487 - Active, not recruiting
  Allergic Rhinitis
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002922 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Microbiological Characterization and Nasal Carriage Rates of Methicillin Resistant Staphylococcus Aureus (MRSA) in Vancouver Downtown Eastside
  ClinicalTrials.gov Identifier: NCT00247871 - Active, not recruiting
  Nasal Colonization With MRSA Bacteria
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
  ClinicalTrials.gov Identifier: NCT00458835 - Active, not recruiting
  Allergic Rhinitis
  
• Comparator Study Evaluating Patient Preference Of Fluticasone Furoate Nasal Spray vs. Fluticasone Propionate Nasal Spray
  ClinicalTrials.gov Identifier: NCT00539006 - Active, not recruiting
  Seasonal Allergic Rhinitis
  
• Cigarette Smoke Nasal and Whole Blood Challenge in Patients with COPD
  ClinicalTrials.gov Identifier: NCT00159341 - Recruiting
  Lung Diseases, Obstructive
  
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003443 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Association of L-Asparaginase-Methotrexate–Dexamethasone for Nasal and Nasal-Type Natural Killer (NK)-T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00283985 - Recruiting
  Lymphoma, Non-Hodgkin
  
• Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00215787 - Recruiting
  Nasal Polyps; Gastroesophageal Reflux
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• A Study to Evaluate a Once-Daily Investigational Nasal Spray in Adults and Adolescents with Seasonal Allergic Rhinitis (SAR)
  ClinicalTrials.gov Identifier: NCT00115622 - Active, not recruiting
  Rhinitis, Allergic, Seasonal
  
• Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between the Ages of 6 and Less Than 18 Years Old (Study P04292)
  ClinicalTrials.gov Identifier: NCT00378378 - Recruiting
  Nasal Polyps
  
• Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00217568 - Active, not recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• Changes in Nasal Patency with Changes in Posture, Temperature, Humidity and Nasal Patency Seen by Acoustic Rhinometry
  ClinicalTrials.gov Identifier: NCT00147888 - Active, not recruiting
  Mucosal congestion
  
• The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00440219 - Not yet recruiting
  Nasal Polyps
  
• Mint Tea for the Treatment of Nasal Polyps
  ClinicalTrials.gov Identifier: NCT00465543 - Recruiting
  Nasal Polyps
  
• RCT of Nasal Turbinate Reduction to Improve CPAP Outcomes for Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00503802 - Recruiting
  Sleep Apnea Syndromes; Nasal Obstruction; Turbinate Hypertrophy
  
• Placebo-Controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)
  ClinicalTrials.gov Identifier: NCT00553891 - Recruiting
  Nasal Obstruction; Adenoids Hypertrophy; Adenoidectomy
  
• Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003908 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
  
• Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00217555 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Topotecan in Treating Patients With Progressive or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00287859 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003850 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; metastatic squamous neck cancer with occult primary squamous cell carcinoma; ...
  
• Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00217529 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Quality of Life and Development of Measures in Patients With Cancer of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00582413 - Recruiting
  Cancer of the Oral Cavity
  
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00354601 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002555 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00002670 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
  ClinicalTrials.gov Identifier: NCT00049166 - Active, not recruiting
  stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ...
  
• Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)
  ClinicalTrials.gov Identifier: NCT00552110 - Recruiting
  Seasonal Allergic Rhinitis
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002476 - Active, not recruiting
  Oropharyngeal Cancer; Head and Neck Cancer; lip and oral cavity cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004097 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00009841 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002894 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Hypnosis, Massage Therapy, and Healing Touch in Treating Patients Receiving Chemotherapy for Ovarian Epithelial Cancer or Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00293293 - Recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00045682 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer
  
• Effects of Sublingual Immunotherapy on Grasspollen Allergy
  ClinicalTrials.gov Identifier: NCT00150514 - Completed
  Hayfever
  
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00011999 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
  ClinicalTrials.gov Identifier: NCT00377247 - Recruiting
  Primary Advanced Carcinoma of the Oral Cavity or Oropharynx; Squamous Cell Carcinoma of the Head and Neck
  
• Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005046 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Safety Study To Assess Growth In Pre-Pubertal Children Treated With An Investigational Nasal Spray For Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00109486 - Active, not recruiting
  Hayfever; Allergic Rhinitis; Seasonal rhinitis; Perennial Rhinitis; Non-Seasonal rhinitis
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00023712 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Sorafenib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00093626 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004070 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer.
  ClinicalTrials.gov Identifier: NCT00148122 - Recruiting
  Squamous cell cancer of the oral cavity and pharynx
  
• Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004081 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Sorafenib and Gemcitabine in Treating Patients With Recurrent or Refractory Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00096395 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Suberoylanilide Hydroxamic Acid in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00132067 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Lapatinib in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00114283 - Suspended
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00054119 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Fluticasone Nasal Spray Patient Preference Study
  ClinicalTrials.gov Identifier: NCT00398476 - Active, not recruiting
  Allergic Rhinitis
  
• Evaluation Of Cloumella Strut Effect In Tip Rotation
  ClinicalTrials.gov Identifier: NCT00467714 - Active, not recruiting
  Nasal Deformity
  
• Intranasal Steroids and the Nasal Ocular Response
  ClinicalTrials.gov Identifier: NCT00473915 - Active, not recruiting
  Seasonal Allergic Rhinitis
  
• Safety Study of Olpatadine Nasal Spray
  ClinicalTrials.gov Identifier: NCT00578331 - Active, not recruiting
  Perennial Allergic Rhinitis
  
• Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00113373 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00006361 - Active, not recruiting
  lip and oral cavity cancer; Skin Cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• BMS-247550 in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00025155 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
  ClinicalTrials.gov Identifier: NCT00085358 - Recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00020696 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00086892 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00041041 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00087087 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00047008 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00005944 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; peritoneal cavity cancer; liver metastases; recurrent rectal cancer; ...
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006028 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003251 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
  ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
  Hayfever; Allergic Rhinitis
  
• Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx
  ClinicalTrials.gov Identifier: NCT00002702 - Recruiting
  stage II squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the lip and oral cavity; ...
  
• AZD2171 in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00278343 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
  ClinicalTrials.gov Identifier: NCT00012090 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00562640 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Radiation Therapy With or Without Epoetin alfa in Anemic Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004917 - Active, not recruiting
  Anemia; Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004094 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the nasopharynx; ...